| 영문 | dengue fever | 한글 | 뎅기 |
|---|---|---|---|
| 설명 | 주로 열대지방에서 발생하는 바이러스성 열병. 4~8일의 잠복기를 거쳐 급격하게 발열하고, 결막충혈-관절통-근육통-백혈구감소 등의 증상을 보인다. 대부분 7~10일 후에는 회복되며, 사망하는 예는 드물다. 미국의 세균학자인 C.F. 크레이그는 1907년 필리핀에서 뎅기열은 모기에 의해 감염된다는 것을 확인-보고했다. 제2차 세계대전 직후 미국의 세균학자 A. B. 세이빈은 그의 연구에 의해 뎅기열 바이러스에는 면역학적으로 네가지 형이 있다고 밝혔다. 뎅기열 바이러스를 매개하는 모기에는 이집트숲모기(Aedes aegypti)와 흰줄숲모기(Aedes albopictus)가 알려져 있다. 이 병에 걸리고 나면 면역이 생기지만 지속기간은 비교적 짧다. |
||
| 영문 | shock | 한글 | 쇼크, 충격 |
|---|---|---|---|
| 설명 | 1. 정신적 평형의 돌연한 장애. 2. 어떠한 원인으로 진행성인 말초순환부족의 결과로 조직의 산소부족증을 일으켜 탄산가스나 유산등의 대사산물의 축적을 일으킨 상태를 말한다. 쇼크의 임상증상은 ① 피부의 창백, ② 손발톱모세혈관의 재충만 지연, ③ 의식장애, ④ 혈압하강, 맥박긴장저하, ⑤ 요량감소 등이다. 쇼크의 분류에는 1차성쇼크, 2차성쇼크가 있으며 순환동태에 의한 분류로서 저혈류량성쇼크, 말초혈관확장성쇼크, 심장성쇼크가 있다. 병인적인 분류로서 신경탓쇼크, 아나피락시스쇼크, 국소마취약 중독의 결과로 일어나는 쇼크 등이 있다. |
||
| 영문 | testicular feminization syndrome | 한글 | 고환여성화증후군 |
|---|---|---|---|
| 설명 | 이차성장을 포함하여, 외성기의 발육은 여성이지만 고환이 존재하고, 자궁과 자궁관이 결핍되어 있는 남성 거짓남녀한몸증의 극단적 형태이다. 이것은 테스토스테론의 작용에 대한 말단기관의 저항에 기인한다. |
||
| 영문 | irritable bowel syndrome | 한글 | 과민성대장증후군 |
|---|---|---|---|
| 설명 | 배변장애, 복통, 복부팽만 등의 증상이 있으나 기질적인 병변이 없음이 확인된 예를 총망라한 임상 증후군이다. 가장 흔한 소화기 질환이며(전소화기 환자의 70~80%) 가장 흔한 질병(전체 인구의 약 20%)이다. 여성이 남성에 비해 2배 정도 많이 발생하며 30대 및 40대에서 호발하고 선진 공업국에서 많이 발생한다. 진단을 위해서는 병력 청취가 가장 중요하고 각종 검사로서 기질병을 제외해야 한다. 치료로는 안정요법(정신과적 면담 및 심리요법, 신경안정제), 식사요법(고섬유질 음식 섭취, 자극성 음식 피하기), 약물 요법(창자경련 진정제, 변비 완화제, 지사제) 등을 사용한다. |
||
| 영문 | withdrawal syndrome | 한글 | 금단증후근 |
|---|---|---|---|
| 설명 | 알코올, 마약, 바비투르산계 최면약 등의 약물을 장기간 복용하여 약물이 없이는 견딜 수 없게된 뒤, 그 약물을 중지한 경우에 나타나는, 고통이 수반되는 신체적 증상을 말한다. 연속 복용의 기간에 따라 증상이 무거워진다. 통상적으로 구토, 설사, 혈압상승, 빠른맥, 땀남, 혼수 등의 증상이 나타난다. |
||
| DHF/DSS | dengue hemorrhagic fever/ dengue shock syndrome |
|---|---|
| DSS | 1) Double Simultaneous Stimulation 2) Dengue Shock Syndrome |
| DSS | dengue shock syndrome; dioctyl sodium sulfosuccinate; Disability Status Scale; discrete subaortic st... |
| CS | calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ... |
| MS | Maffuci syndrome; maladjustment score; mandibular series; Marfan syndrome; Marie-Strumpell [syndrome... |
| DHF/DSS | Dengue Haemorrhagic Fever/Dengue Shock Syndrome |
|---|---|
| DSS | Dengue Shock Syndrome |
| DEN | Dengue |
| DEN 2 | Dengue 2 |
| DF | Dengue Fever |
| dengue shock syndrome | <syndrome> Dengue fever of grade III or IV severity. (05 Mar 2000) |
|---|---|
| dengue | Tropical disease caused by a flavivirus (one of the arboviruses), transmitted by mosquitoes. A more serious complication is dengue shock syndrome, a haemorrhagic fever probably caused by an immune complex hypersensitivity after re exposure. (18 Nov 1997) |
| dengue fever | <microbiology> A tropical disease caused by dengue virus (Arbovirus), that is transmitted by the bite of an infected mosquito of the genus Aedes). Four severity grades of the illness are seen: grade I (fever and constitutional symptoms), grade II (grade I plus spontaneous bleeding of skin, gums or gastrointestinal tract), grade III (grade II plus agitation and circulatory failure) and grade IV (profound shock). Grade I infection is seen most frequently in world travelers, where it is usually self-limited and rarely fatal. The other grades are referred to as dengue haemorrhagic fever and are often fatal. Dengue haemorrhagic fever appears to be an infection by one of the other dengue viruses. Prior immunity to a different dengue virus type appears to be important in the development of the more serious haemorrhagic form. Vaccines are available. Protection from mosquitoes is an important preventive measure. (27 Sep 1997) |
| dengue haemorrhagic fever | <microbiology> A tropical disease caused by dengue virus (Arbovirus), that is transmitted by the bite of an infected mosquito of the genus Aedes). Four severity grades of the illness are seen: grade I (fever and constitutional symptoms), grade II (grade I plus spontaneous bleeding of skin, gums or gastrointestinal tract), grade III (grade II plus agitation and circulatory failure) and grade IV (profound shock). Grade I infection is seen most frequently in world travelers, where it is usually self-limited and rarely fatal. The other grades are referred to as dengue haemorrhagic fever and are often fatal. Dengue haemorrhagic fever appears to be an infection by one of the other dengue viruses. Prior immunity to a different dengue virus type appears to be important in the development of the more serious haemorrhagic form. Vaccines are available. Protection from mosquitoes is an important preventive measure. (27 Sep 1997) |
| dengue virus | A species of the genus flavivirus which causes an acute febrile and sometimes haemorrhagic disease in man. Dengue is mosquito-borne and four serotypes are known. (12 Dec 1998) |
| syndrome, toxic shock | A grave condition occurring predominantly in menstruating women using tampons, toxic shock is characterised by a highly toxic state (with sudden high fever, vomiting, diarrhoea, muscle aching) followed by low blood pressure (hypotension) which can lead to shock (and death). There may be a rash resembling sunburn with peeling of skin. The channing laboratory in boston under dr. Edw. Kass discovered that toxic shock was due to a toxin produced by staph (staphylococcus) aureus bacteria growing under conditions with little or no oxygen. The syndrome occurs rarely in women not using tampons and in men. (12 Dec 1998) |
| toxic shock syndrome | <syndrome> A blood-borne bacterial infection caused by the genus Staphylococcus. Usually effects menstruating females under the age of thirty and was associated in the past with the use of a particular type of tampon (no longer used). Common symptoms include: fever, chills, vomiting, sore throat, headache and decreased urine output. Progression of disease can result in lowering of blood pressure (shock) and renal failure. Treatment includes hospitalisation and intravenous antibiotics emergently. (27 Sep 1997) |
| anaesthetic shock | Shock produced by the administration of anaesthetic drug(s), usually in relative overdosage. (05 Mar 2000) |
| anaphylactic shock | <immunology> A serious, often life-threatening allergic reaction that is characterised by low blood pressure, shock (poor tissue perfusion) and difficulty breathing. (27 Sep 1997) |
| anaphylactoid shock | A reaction that is similar to anaphylactic shock, but which does not require the incubation period characteristic of induced sensitivity (anaphylaxis); it is unrelated to antigen-antibody reactions. Synonym: anaphylactoid crisis, pseudoanaphylactic shock. (05 Mar 2000) |
| break shock | The shock produced by breaking a constant current passing through the body. (05 Mar 2000) |
| cardiac shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
| cardiogenic shock | A form of shock (inadequate delivery of oxygen to the tissues) that occurs secondary to the weakened pumping function of the heart. This condition may be precipitated by myocardial infarction or cardiomyopathy. Treatment includes fluid restriction, diuretics, vasopressors (dopamine) to support the blood pressure and the use of intravenous medications (dobutamine) which stimulate the heart to contract more forcefully. (27 Sep 1997) |
| cardiopulmonary obstructive shock | <cardiology> This term describes a number of conditions that involve a severe disturbance of the cardiopulmonary circuit resulting in shock (inadequate delivery of oxygen to the tissues). Examples include: pulmonary embolism, pericardial tamponade, pneumothorax and constrictive pericarditis. (27 Sep 1997) |
| vasogenic shock | Shock resulting from depressed activity of the higher vasomotor centres in the brain stem and the medulla, producing vasodilation without loss of fluid so that the container is disproportionately large. In oligaemic shock, blood volume is reduced; in both, return of venous blood is inadequate. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|